In India, many of us have heard about jaundice or liver infections, often brushing them off as minor ailments. But what if these seemingly harmless conditions are silently paving the way for something as serious as liver cancer? It’s a reality that many remain unaware of: chronic infections like Hepatitis B and Hepatitis C can significantly elevate the risk of developing liver cancer.
Understanding this connection is crucial, especially in a country where awareness about liver health is still growing. Let’s explore how these infections impact our liver and why timely intervention is essential.
What Are Hepatitis B and C?
To truly understand how these viruses lead to cancer, we first need to grasp what they are and how they affect the liver.
Understanding Hepatitis B
Hepatitis B is a DNA virus that primarily infects the liver. It spreads through contact with infected blood or other body fluids. This can happen through sharing needles for injections, unprotected intercourse, or from a mother to her baby during childbirth. Many people who contract Hepatitis B experience a short, acute illness and then clear the virus. However, for some, particularly those infected at a young age, the infection becomes chronic. This means the virus stays in the body for a long time, sometimes for life, continuously attacking liver cells.
Understanding Hepatitis C
Hepatitis C, on the other hand, is an RNA virus that also targets the liver. It’s predominantly transmitted through blood-to-blood contact, often associated with sharing contaminated needles for drug use, unsterile medical procedures, or, in the past, through blood transfusions before widespread screening became routine. Similar to Hepatitis B, a significant portion of individuals infected with Hepatitis C will develop a chronic infection. What makes Hepatitis C particularly insidious is that it often causes no noticeable symptoms for many years, earning it the nickname “the silent killer.” People can live with it for decades without knowing, while the virus silently damages their liver.
How Chronic Infection Leads to Cancer
The journey from chronic hepatitis infection to liver cancer is a gradual process, marked by inflammation, scarring, and ultimately, uncontrolled cell growth. Let’s break down the key steps:
Persistent Inflammation
Both viruses cause long-term inflammation in the liver. In simple terms, the body’s defence cells pick a fight with the virus, but in doing so, also harm healthy liver tissue.
Cellular Repair Gone Wrong
When liver cells are damaged, they try to repair themselves. Over the years, this repeated cycle of injury and repair can lead to scars (fibrosis) and, eventually, cirrhosis—a condition where the liver becomes hard and lumpy.
Mutation and Cancer Development
As scars form, the repair process sometimes makes mistakes in the DNA of new liver cells. These mistakes can turn normal cells into cancer cells. When cancer starts in the liver, it is called hepatocellular carcinoma (HCC).
Beyond this general pathway, Hepatitis B and Hepatitis C have specific ways they can contribute to cancer:
Hepatitis B’s Direct Impact
The Hepatitis B virus can insert its own genetic material (DNA) directly into the DNA of liver cells. This integration can disrupt normal cell growth controls and activate genes that promote cancer development. The virus also produces a protein called HBx, which can interfere with various cellular processes, including cell cycle regulation and programmed cell death, pushing cells towards uncontrolled growth.
Hepatitis C’s Indirect Influence
While Hepatitis C doesn’t directly insert its DNA into host cells, it creates an environment of oxidative stress within the liver. This stress leads to the production of harmful molecules that can damage cellular DNA, further increasing the risk of mutations and cancer. Hepatitis C also promotes metabolic changes in the liver, such as steatosis (fatty liver), which can accelerate the progression to fibrosis and cirrhosis, and subsequently, cancer.
The Hidden Symptoms and Early Detection
One of the most challenging aspects of liver cancer, especially when caused by hepatitis, is its silent nature in the early stages. Often, symptoms only appear when the cancer has grown considerably or is advanced. This makes early detection crucial.
Common symptoms, if they do appear, can include:
- Unexplained weight loss
- Loss of appetite
- Feeling full after eating only a small amount
- Nausea or vomiting
- Pain in the upper right side of the abdomen or near the right shoulder blade
- Swelling in the abdomen (ascites)
- Yellowing of the skin and eyes (jaundice)
- Pale stools or dark urine
- Fatigue and weakness
If you have chronic Hepatitis B or Hepatitis C, it is vital to be aware of these potential signs and report them to your doctor immediately. Regular screening for liver cancer, typically involving ultrasound and blood tests for tumor markers like alpha-fetoprotein (AFP), is strongly recommended for individuals with chronic hepatitis, even if they feel well. This is particularly important in India, where the prevalence of these infections is high.
Prevention and Management
The good news is that much can be done to reduce the risk of liver cancer due to hepatitis.
Prevention is Key
Protecting your liver starts with proactive measures:
Vaccination for Hepatitis B
The Hepatitis B vaccine is highly effective and widely available. It’s a crucial preventive measure, especially for newborns and individuals at higher risk. Universal vaccination programs have significantly reduced the incidence of Hepatitis B infection and, consequently, liver cancer in many regions.
Preventing Hepatitis C Transmission
There is no vaccine for Hepatitis C. Prevention relies on avoiding exposure to infected blood. This includes:
- Never sharing needles for drug use.
- Ensuring sterile equipment is used for tattoos, piercings, and medical procedures.
- Practicing safe intercourse.
Screening and Early Diagnosis
Given the silent nature of both infections, testing is essential. Everyone, especially those born between 1945 and 1965 (the “baby boomer” generation, though this applies more broadly in India where historical screening was less common), and individuals with risk factors, should get tested for both Hepatitis B and Hepatitis C. Early diagnosis means earlier treatment and a better chance of preventing serious liver damage and cancer.
Lifestyle Choices
Maintaining a healthy weight, limiting alcohol consumption, and avoiding smoking can further reduce the burden on the liver and lower the risk of liver disease progression.
Managing Existing Infections
If you’ve been diagnosed with Hepatitis B or C, the right treatment can slow down liver damage and reduce the risk of cancer.
- Antiviral Treatment for Hepatitis B: While Hepatitis B is not curable, effective antiviral medications can suppress the virus, reduce liver inflammation, prevent the progression to cirrhosis, and significantly lower the risk of liver cancer due to hepatitis. Regular monitoring by a specialist is crucial.
- Direct-Acting Antivirals (DAAs) for Hepatitis C: The landscape of Hepatitis C treatment has been revolutionized by direct-acting antiviral medications. These medications can cure Hepatitis C in most people (over 90% success rate), even those with cirrhosis. Curing the infection drastically reduces the risk of liver cancer and can even lead to improvement in liver function. Even if cirrhosis has developed, treating Hepatitis C still significantly lowers the risk of liver cancer.
When Cancer Strikes: Treatment Options
Despite effective hepatitis prevention and treatment strategies, liver cancer can still develop. When it does, the choice of treatment depends significantly on the stage of the cancer, the extent of liver damage, and the patient’s overall health. In India, a wide range of advanced treatment options is available, tailored to match the stage and severity of the disease:
Surgery (Early Stage)
For patients with a localized tumor and good liver function, partial hepatectomy (surgical removal of the tumor-bearing portion of the liver) offers a potential cure. This is most suitable when the cancer is confined and the remaining liver is healthy enough to function post-surgery.
Ablation Therapies (Very Early to Early Stage)
Techniques such as radiofrequency ablation (RFA) or microwave ablation (MWA) are ideal for small tumors (usually less than 3 cm), especially in patients who are not surgical candidates. These minimally invasive procedures destroy cancer cells using heat or cold.
Transarterial Chemoembolization (TACE) and Transarterial Radioembolization (TARE) (Intermediate Stage)
For patients with tumors that are too large or numerous for surgery but have not yet spread extensively, these targeted therapies deliver chemotherapy or radioactive particles directly to the liver tumor via the hepatic artery, helping control cancer growth while preserving healthy tissue.
Systemic Therapies (Advanced Stage)
In cases where liver cancer has spread beyond the liver or into blood vessels, systemic treatments like targeted therapies and immunotherapy (e.g., checkpoint inhibitors) can help slow disease progression and improve survival.
Liver Transplant (Very Early to Early Stage)
For patients with small tumors who also have severe underlying liver disease, a liver transplant offers the best chance of long-term survival or cure. This involves replacing the diseased liver with a healthy one from a deceased or living donor and is typically considered for patients meeting specific transplant criteria (such as the Milan criteria).
Conclusion
The risk of liver cancer due to hepatitis is a growing concern, especially in regions like India. Awareness, timely screenings, and preventive measures are our best defense against this silent threat.
If you or someone you know is dealing with Hepatitis B, Hepatitis C, or any liver-related issues, it’s essential to consult with a specialist. Dr. A.S. Soin, a renowned liver transplant surgeon in India, offers expert care and guidance for those facing liver health challenges.
Prioritize your liver health today. Early action can lead to better outcomes tomorrow.
